Navigation Links
DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
Date:3/13/2013

Denver, CO (PRWEB) March 13, 2013

The birth control resource center at DrugRisk.com is alerting women who have taken the contraceptives Yaz or Yasmin of new information on the site showing drug maker Bayer has spent around $1 billion so far to settle Yaz lawsuits, and has reserved a remaining $500 million to resolve new claims.

“The goal of DrugRisk is to improve the safety of those taking prescription drugs by publishing the latest warnings, recalls, studies and litigation news. Informed patients can discuss concerns with their doctor and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.

The resource center has reported that thousands of patients have filed a Yaz lawsuit, which have been consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Injury claims came after studies from the British Medical Journal and FDA warned that birth control pills containing the hormone drospirenone, such as Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.*

DrugRisk has uncovered the latest financial reports from Bayer, which show the company faces Yaz lawsuits from as many as 13,600 claimants.** Bayer also disclosed they have spent around $1 billion so far to settle nearly 4,800 patient claims for blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism.**

Now, the resource center has learned that Bayer had set aside a total of $1.5 billion to resolve Yaz lawsuits, of which $500 million still remains to settle claims which are still pending or have yet to be filed.*** This is positive news for patients who have suffered blood clot injuries but have not filed a case.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury litigation, DrugRisk cautions that patients should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects of yaz and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
**Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013
***newsandinsight.thomsonreuters.com/Legal/News/2013/03_-_March/Bayer_reserves_$1_5_bln_to_cover_Yasmin,_Yaz_lawsuits/

Read the full story at http://www.prweb.com/releases/side-effects-of-yaz/lawsuits/prweb10518343.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
2. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
3. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
4. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
7. DrugRisk Announces Updated Information on Mirena Lawsuits
8. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
9. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
10. Tylenol Liver Failure Allegation Lawsuits Update: Resource4thePeople Reports Hearing to Consolidate Federal Cases Is Scheduled
11. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Michael and ... Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as ... has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Christmas in ... creation of published author, Sara Seymour, who lives in Lafayette, Indiana where she works ... sips on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the German ... Germany , has purchased a MRIdian ... Clinic Heidelberg as part of its initiative for MRI-based ... be headed by Medical Director and Professor Jürgen Debus, ... German Cancer Research Center (DKFZ), the Heidelberg Heavy Ion ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: